XML 271 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Changes in Equity - EUR (€)
Total
Share capital and capital reserve
Share based compensation reserve
Founder preferred shares dividend reserve
Translation reserve
Cash flow hedging reserve
Accumulated deficit reserve
Equity attributable to owners of parent [member]
Non-controlling interests [member]
Founder Preferred shares
Founder preferred shares dividend reserve
Equity € 1,902,500,000                  
Equity, beginning balance at Dec. 31, 2016   € 1,800,700,000 € 1,000,000 € 493,400,000 € 84,000,000 € 8,400,000 € (485,000,000) € 1,902,500,000    
Profit (loss) 136,500,000           136,500,000 136,500,000    
Other comprehensive (loss)/income for the year (11,300,000)       (800,000) (11,400,000) 900,000 (11,300,000)    
Comprehensive income 125,200,000       (800,000) (11,400,000) 137,400,000 125,200,000    
Purchase of treasury shares 177,100,000 177,100,000           177,100,000    
Listing and share transaction costs (500,000) (500,000)           (500,000)    
Increase (decrease) through share-based payment transactions, equity 2,600,000   2,600,000         2,600,000    
Vesting of Non-Executive Restricted Stock award (100,000) 600,000 (700,000)         (100,000)    
Total transaction with owners, recognized directly in equity (175,100,000) (177,000,000) 1,900,000         (175,100,000)    
Equity, ending balance at Dec. 31, 2017   1,623,700,000 2,900,000 493,400,000 83,200,000 (3,000,000) (347,600,000) 1,852,600,000    
Equity 1,852,600,000                  
Equity attributable to owners of the parent (restated)   1,623,700,000 2,900,000 493,400,000 83,200,000 (3,000,000) (329,500,000) 1,870,700,000    
Equity (restated) 1,870,700,000                  
Fair value gain (loss) that would have been recognised in profit or loss or other comprehensive income if financial liabilities had not been reclassified as measured at amortised cost, initial application of IFRS 9 18,100,000           18,100,000 18,100,000    
Profit (loss) 170,500,000           171,200,000 171,200,000 € (700,000)  
Other comprehensive (loss)/income for the year 7,500,000       5,600,000 11,500,000 (9,600,000) 7,500,000    
Comprehensive income 178,000,000       5,600,000 11,500,000 161,600,000 178,700,000 (700,000)  
Founder Preferred Shares Annual Dividend Amount   (120,800,000)   120,800,000            
Listing and share transaction costs 0                  
Increase (decrease) through share-based payment transactions, equity 13,000,000   13,000,000         13,000,000    
Non controlling interest through acquisition of subsidiary (100,000)               (100,000)  
Vesting of Non-Executive Restricted Stock award (200,000) 600,000 (800,000)         (200,000)    
Issue of equity 100,000 3,400,000 (3,300,000)         100,000    
Reclassification of awards for settlement of tax liabilities (2,400,000)   (2,400,000)         (2,400,000)    
Total transaction with owners, recognized directly in equity 10,400,000 124,800,000 6,500,000 (120,800,000)       10,500,000 (100,000)  
Equity, ending balance at Dec. 31, 2018 2,059,900,000 1,748,500,000 9,400,000 372,600,000 88,800,000 8,500,000 (167,900,000) 2,059,900,000    
Equity 2,059,100,000               (800,000.0) € 372,600,000
Equity attributable to owners of the parent (restated)   1,748,500,000 9,400,000 372,600,000 88,800,000 8,500,000 (136,600,000) 2,091,200,000    
Equity (restated) 2,090,400,000                  
Opening balance sheet restatement IFRS 16 31,300,000           31,300,000 31,300,000    
Profit (loss) 153,600,000           154,000,000 154,000,000 (400,000)  
Other comprehensive (loss)/income for the year (44,900,000)       6,000,000 (21,700,000) (29,200,000) (44,900,000)    
Comprehensive income 108,700,000       6,000,000 (21,700,000) 124,800,000 109,100,000 (400,000)  
Founder Preferred Shares Annual Dividend Amount   (2,500,000)   2,500,000       0   (2,500,000)
Listing and share transaction costs (11,100,000) (11,100,000) 0         (11,100,000)    
Increase (decrease) through share-based payment transactions, equity 14,900,000   14,900,000         14,900,000    
Vesting of Non-Executive Restricted Stock award (800,000) 0 (800,000)         (800,000)    
Issue of equity 354,200,000 355,500,000 (1,300,000)         354,200,000    
Reclassification of awards for settlement of tax liabilities 400,000   400,000         400,000    
Total transaction with owners, recognized directly in equity 357,600,000 346,900,000 13,200,000 (2,500,000)       357,600,000 0  
Equity, ending balance at Dec. 31, 2019 2,557,900,000 € 2,095,400,000 € 22,600,000 € 370,100,000 € 94,800,000 € (13,200,000) € (11,800,000) € 2,557,900,000    
Equity € 2,556,700,000               € (1,200,000) € 370,100,000